Benjamin Abuaku1, Linda Eva Amoah2, Nana Yaw Peprah3, Alexander Asamoah3, Eunice Obeng Amoako4, Dickson Donu2, George Asumah Adu3, Keziah Laurencia Malm3. 1. Epidemiology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, P. O. Box LG581, Legon, Ghana. babuaku@noguchi.ug.edu.gh. 2. Immunology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, P. O. Box LG581, Legon, Ghana. 3. National Malaria Control Programme, Public Health Division, Ghana Health Service, Accra, Ghana. 4. Epidemiology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, P. O. Box LG581, Legon, Ghana.
Abstract
BACKGROUND: Parasitological diagnosis generates data to assist malaria-endemic countries determine their status within the malaria elimination continuum and also inform the deployment of proven interventions to yield maximum impact. This study determined prevalence of malaria parasitaemia and mRDT performances among febrile patients in selected health care facilities across Ghana. METHODS: This study was a cross-sectional survey conducted in the previously 10 regions of Ghana from May to August 2018. Each patient suspected to have uncomplicated malaria was tested using microscopy and two malaria rapid diagnostic tests (mRDTs): routinely used CareStart™ Malaria HRP2 (Pf) and SD Bioline Malaria Ag Pf (HRP2/pLDH). Main outcome variables were malaria slide and CareStart™ Malaria HRP2 (Pf) positivity rates; and diagnostic accuracy of CareStart™ Malaria HRP2 (Pf) and SD Bioline Malaria Ag Pf (HRP2/pLDH) using microscopy as "gold standard". RESULTS: Overall parasite positivity rates were 32.3% (6266/19402) by mRDT and 16.0% (2984/18616) by microscopy, with Plasmodium falciparum mono-infection accounting for 98.0% of all infections. The odds of parasitaemia by microscopy was significantly lower among female patients compared with males (OR = 0.78; 95% CI: 0.66-0.91), and among patients with history of previous antimalarial intake compared with those with no such history (OR = 0.72; 95% CI: 0.54-0.95). Overall sensitivity of CareStart™ Malaria HRP2 (Pf) was statistically similar to that of the HRP2 band of SD Bioline Malaria Ag Pf (HRP2/pLDH) combo kit (95.4%; 95% CI: 94.6-96.1 vs 94.3%; 95% CI: 93.4-95.1; p = 0.065) but significantly higher than the pLDH band (89.3%; 95% CI: 88.1-90.4; p < 0.001). The same pattern was observed for negative predictive value. CONCLUSIONS: Malaria control interventions should be targeted at the general population, and history of antimalarial intake considered a key predictor of malaria slide negativity. Furthermore, HRP2-based mRDTs remain effective diagnostic tool in the management of suspected uncomplicated malaria in the country.
BACKGROUND: Parasitological diagnosis generates data to assist malaria-endemic countries determine their status within the malaria elimination continuum and also inform the deployment of proven interventions to yield maximum impact. This study determined prevalence of malaria parasitaemia and mRDT performances among febrile patients in selected health care facilities across Ghana. METHODS: This study was a cross-sectional survey conducted in the previously 10 regions of Ghana from May to August 2018. Each patient suspected to have uncomplicated malaria was tested using microscopy and two malaria rapid diagnostic tests (mRDTs): routinely used CareStart™ MalariaHRP2 (Pf) and SD Bioline Malaria Ag Pf (HRP2/pLDH). Main outcome variables were malaria slide and CareStart™ MalariaHRP2 (Pf) positivity rates; and diagnostic accuracy of CareStart™ MalariaHRP2 (Pf) and SD Bioline Malaria Ag Pf (HRP2/pLDH) using microscopy as "gold standard". RESULTS: Overall parasite positivity rates were 32.3% (6266/19402) by mRDT and 16.0% (2984/18616) by microscopy, with Plasmodium falciparum mono-infection accounting for 98.0% of all infections. The odds of parasitaemia by microscopy was significantly lower among female patients compared with males (OR = 0.78; 95% CI: 0.66-0.91), and among patients with history of previous antimalarial intake compared with those with no such history (OR = 0.72; 95% CI: 0.54-0.95). Overall sensitivity of CareStart™ MalariaHRP2 (Pf) was statistically similar to that of the HRP2 band of SD Bioline Malaria Ag Pf (HRP2/pLDH) combo kit (95.4%; 95% CI: 94.6-96.1 vs 94.3%; 95% CI: 93.4-95.1; p = 0.065) but significantly higher than the pLDH band (89.3%; 95% CI: 88.1-90.4; p < 0.001). The same pattern was observed for negative predictive value. CONCLUSIONS:Malaria control interventions should be targeted at the general population, and history of antimalarial intake considered a key predictor of malaria slide negativity. Furthermore, HRP2-based mRDTs remain effective diagnostic tool in the management of suspected uncomplicated malaria in the country.
Entities:
Keywords:
Health care facilities; Malaria parasitaemia; Symptomatic individuals
Authors: D Moonasar; N Morris; I Kleinschmidt; R Maharaj; J Raman; N T Mayet; F G Benson; D N Durrheim; L Blumberg Journal: S Afr Med J Date: 2013-08-29
Authors: Fredrick Kateera; Petra F Mens; Emmanuel Hakizimana; Chantal M Ingabire; Liberata Muragijemariya; Parfait Karinda; Martin P Grobusch; Leon Mutesa; Michèle van Vugt Journal: Malar J Date: 2015-01-21 Impact factor: 2.979
Authors: Dennis Adu-Gyasi; Kwaku Poku Asante; Sabastina Amoako; Nicholas Amoako; Love Ankrah; David Dosoo; Samuel Kofi Tchum; George Adjei; Oscar Agyei; Seeba Amenga-Etego; Seth Owusu-Agyei Journal: PLoS One Date: 2018-09-07 Impact factor: 3.240
Authors: Isabella A Quakyi; George O Adjei; David J Sullivan; Amos Laar; Judith K Stephens; Richmond Owusu; Peter Winch; Kwame S Sakyi; Nathaniel Coleman; Francis D Krampa; Edward Essuman; Vivian N A Aubyn; Isaac A Boateng; Bernard B Borteih; Linda Vanotoo; Juliet Tuakli; Ebenezer Addison; Constance Bart-Plange; Felix Sorvor; Andrew A Adjei Journal: Malar J Date: 2018-12-14 Impact factor: 2.979
Authors: Fredi Alexander Diaz-Quijano; Ruth Aralí Martínez-Vega; Alfonso J Rodriguez-Morales; Ronald Alexander Rojas-Calero; María Lucrecia Luna-González; Ronald Giovanny Díaz-Quijano Journal: BMC Public Health Date: 2018-01-16 Impact factor: 3.295
Authors: Benjamin Abuaku; Collins Ahorlu; Paul Psychas; Philip Ricks; Samuel Oppong; Sedzro Mensah; William Sackey; Kwadwo A Koram Journal: Parasit Vectors Date: 2018-10-23 Impact factor: 3.876
Authors: Linda E Amoah; Kwame K Asare; Donu Dickson; Sherik-Fa Anang; Abena Busayo; Dorcas Bredu; George Asumah; Nana Peprah; Alexander Asamoah; Benjamin Abuaku; Keziah L Malm Journal: Parasit Vectors Date: 2022-01-28 Impact factor: 3.876